Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 30246 | 172 | 15.7 | 47% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
| 156 | 3 | MYCOSES//MYCOLOGY//CANDIDA ALBICANS | 62026 |
| 1247 | 2 | ONYCHOMYCOSIS//DERMATOPHYTES//DERMATOPHYTOSIS | 8986 |
| 30246 | 1 | FARM IST MICROBIOL//FENTICONAZOLE NITRATE//FENTICONAZOLE | 172 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | FARM IST MICROBIOL | address | 399445 | 2% | 75% | 3 |
| 2 | FENTICONAZOLE NITRATE | authKW | 355064 | 1% | 100% | 2 |
| 3 | FENTICONAZOLE | authKW | 228252 | 2% | 43% | 3 |
| 4 | 1 4 DIARYLPYRROLE DERIVATIVES | authKW | 177532 | 1% | 100% | 1 |
| 5 | 2 METHYLIMIDAZOLE DERIVATIVE | authKW | 177532 | 1% | 100% | 1 |
| 6 | 2 METHYLIMIDAZOLONE DERIVATIVE | authKW | 177532 | 1% | 100% | 1 |
| 7 | 3 ARYLACRYLOHYDRAZIDES | authKW | 177532 | 1% | 100% | 1 |
| 8 | 4 ARYLIDEN 2 IMIDAZOLIN 5 ONES | authKW | 177532 | 1% | 100% | 1 |
| 9 | AMINE DISPLACEMENT | authKW | 177532 | 1% | 100% | 1 |
| 10 | ANTICANDIDA AGENT | authKW | 177532 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Chemistry, Medicinal | 1844 | 31% | 0% | 53 |
| 2 | Pharmacology & Pharmacy | 1527 | 55% | 0% | 94 |
| 3 | Mycology | 273 | 5% | 0% | 9 |
| 4 | Medicine, Research & Experimental | 125 | 11% | 0% | 19 |
| 5 | Dermatology | 85 | 6% | 0% | 10 |
| 6 | Chemistry, Multidisciplinary | 52 | 14% | 0% | 24 |
| 7 | Chemistry, Organic | 43 | 9% | 0% | 15 |
| 8 | Toxicology | 29 | 5% | 0% | 8 |
| 9 | Biology | 2 | 2% | 0% | 3 |
| 10 | Infectious Diseases | 2 | 2% | 0% | 3 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | FARM IST MICROBIOL | 399445 | 2% | 75% | 3 |
| 2 | CENT S 1143 NANPEIDAI | 177532 | 1% | 100% | 1 |
| 3 | DEV ERBAMONT GRP | 177532 | 1% | 100% | 1 |
| 4 | IFR GRP ETUD INTERACT HOTE PATHOGENE 149 | 177532 | 1% | 100% | 1 |
| 5 | PHARMACOCHIM GRP ER RECOMMANDEE | 177532 | 1% | 100% | 1 |
| 6 | CATTEDRA MICROBIOL PLICATA | 142019 | 2% | 20% | 4 |
| 7 | CATTEDRA MICROBIOL PL | 118352 | 1% | 33% | 2 |
| 8 | STUDIO MECCANISMI REAZ | 92456 | 3% | 10% | 5 |
| 9 | BIOL PHARM ENGINEER | 88765 | 1% | 50% | 1 |
| 10 | FARM IST FARMACOL FARMACOGNOSIA | 88765 | 1% | 50% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | FARMACO-EDIZIONE SCIENTIFICA | 30814 | 7% | 1% | 12 |
| 2 | MYKOSEN | 21064 | 5% | 1% | 8 |
| 3 | FARMACO | 17138 | 8% | 1% | 13 |
| 4 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 4881 | 6% | 0% | 11 |
| 5 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 3700 | 6% | 0% | 10 |
| 6 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 3216 | 8% | 0% | 13 |
| 7 | MEDICINAL CHEMISTRY RESEARCH | 2732 | 4% | 0% | 7 |
| 8 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH | 1664 | 2% | 0% | 3 |
| 9 | ARCHIV DER PHARMAZIE | 1025 | 3% | 0% | 5 |
| 10 | JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 751 | 2% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | VERALDI, S , MILANI, R , (2008) TOPICAL FENTICONAZOLE IN DERMATOLOGY AND GYNAECOLOGY CURRENT ROLE IN THERAPY.DRUGS. VOL. 68. ISSUE 15. P. 2183 -2194 | 31 | 89% | 7 |
| 2 | BIAVA, M , PORRETTA, GC , POCE, G , SUPINO, S , SLEITER, G , (2007) NEW PYRROLES WITH POTENTIAL ANTIMYCOBACTERIAL, ANTIFUNGAL AND SELECTIVE COX-2 INHIBITING ACTIVITIES. SYNTHETIC METHODOLOGIES.CURRENT ORGANIC CHEMISTRY. VOL. 11. ISSUE 12. P. 1092-1112 | 28 | 57% | 12 |
| 3 | ODEH, F , FABRY, H , KUHLWEIN, A , NOLTING, S , STARY, A , RUPING, KW , KLASCHKA, F , FEGELER, W , FEGELER, K , AZZOLLINI, E , ET AL (1990) A DOUBLE-BLIND CLINICAL-TRIAL WITH A SINGLE DAILY APPLICATION OF FENTICONAZOLE LOTION VERSUS ECONAZOLE LOTION IN PATIENTS WITH CUTANEOUS MYCOSIS.CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. VOL. 47. ISSUE 1. P. 22-31 | 17 | 89% | 1 |
| 4 | GORLERO, F , MACCHIAVELLO, S , PELLEGATTA, L , AIROLDI, ML , GAFFURI, B , PULICI, L , DECECCO, L , (1994) EVALUATION OF THE EFFICACY AND TOLERABILITY OF 2 DIFFERENT DOSAGES OF FENTICONAZOLE VAGINAL OVULES (600 MG AND 1000 MG) IN PATIENTS WITH VAGINAL TRICHOMONIASIS - A CONTROLLED, DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL VERSUS PLACEBO.CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. VOL. 55. ISSUE 5. P. 510-518 | 11 | 100% | 6 |
| 5 | ZIVALJEVIC, B , GOLUBOVIC, I , SERATLIC, J , NIKOLIC, P , SIMIC, D , MAGDIC, I , MARIC-KREJOVIC, S , MARKOVIC-KNEZEVIC, D , KRSMANOVIC, S , (2012) EFFICIENCY OF FENTICONAZOLE FOR THE TREATMENT OF VAGINAL CANDIDIASIS.SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO. VOL. 140. ISSUE 7-8. P. 469 -474 | 11 | 55% | 0 |
| 6 | PORRETTA, GC , BIAVA, M , FIORAVANTI, R , FISCHETTI, M , MELINO, C , VENZA, F , (1991) CHEMOTHERAPEUTIC-AGENTS WITH AN IMIDAZOLE MOIETY .3. SYNTHESIS AND MICROBIOLOGICAL ACTIVITY OF NEW 1,4-DIARYLIMIDAZOLE AND 1,4-PYRROLIMIDAZOLPHENYLENE DERIVATIVES.FARMACO. VOL. 46. ISSUE 7-8. P. 913-924 | 12 | 100% | 1 |
| 7 | GORLERO, F , BOSCO, P , BARBIERI, M , BERTULESSI, C , PULICI, L , POLVANI, F , DECECCO, L , (1992) FENTICONAZOLE OVULES IN THE TREATMENT OF VAGINAL TRICHOMONAS INFECTIONS - A DOUBLE-BLIND RANDOMIZED PILOT CLINICAL-TRIAL.CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. VOL. 51. ISSUE 3. P. 367-376 | 12 | 92% | 4 |
| 8 | ALTMEYER, P , NOLTING, S , KUHLWEIN, A , COLLI, E , SCATIGNA, M , (1990) EFFECT OF FENTICONAZOLE SPRAY IN CUTANEOUS MYCOSIS - A DOUBLE-BLIND CLINICAL-TRIAL VERSUS CYCLOPYROXOLAMINE SPRAY.JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. VOL. 18. ISSUE 1. P. 61-67 | 12 | 100% | 7 |
| 9 | ATHOWFROST, TAM , FREEMAN, K , MANN, TAN , MARKS, R , VOLLUM, D , WARIN, AP , (1986) CLINICAL-EVALUATION OF FENTICONAZOLE CREAM IN CUTANEOUS FUNGAL-INFECTIONS - A COMPARISON WITH MICONAZOLE CREAM.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 10. ISSUE 2. P. 107-116 | 14 | 100% | 16 |
| 10 | ALTMEYER, P , LUTHER, H , KLASCHKA, F , ODEH, F , FEGELER, W , FEGELER, K , LEISTE, D , AZZOLLINI, E , SCATIGNA, M , (1990) A DOUBLE-BLIND CLINICAL-TRIAL OF FENTICONAZOLE CREAM VERSUS NAFTIFINE CREAM APPLIED ONCE DAILY IN PATIENTS WITH CUTANEOUS MYCOSIS.CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. VOL. 47. ISSUE 1. P. 32-42 | 12 | 86% | 3 |
Classes with closest relation at Level 1 |